Mylan announced that it has received final approval from the FDA for its Abbreviated New Drug Application (ANDA) for Levalbuterol Inhalation Solution, the generic version of Sunovion’s Xopenex ...

March 17, 2005 — The U.S. Food and Drug Administration (FDA) has approved a new indication for temozolomide, allowing its use in the first-line treatment of glioblastoma multiforme; orphan drug status ...

Teva Launches Generic Xopenex Concentrate Teva announced the launch of Levalbuterol Inhalation Solution, the generic version of Xopenex Inhalation Solution Concentrate. Teva announced the launch of ...

Akorn plans to ship product immediately upon closing the transaction and Sunovion will work with Akorn to ensure uninterrupted access to patients. (Akorn) (Akorn) Sunovion Pharmaceuticals Inc. to ...

MARLBOROUGH, Mass. -- Sepracor Inc.'s asthma drug Xopenex was approved by the Food and Drug Administration for use in inhalers, adding an environmentally friendly drug to the market and providing a ...

WASHINGTON The Food and Drug Administration today issued a public health advisory to alert patients, caregivers and healthcare professionals to switch to hydrofluoroalkane propelled albuterol inhalers ...

BOSTON (CBS.MW) -- Shares of Sepracor were on the rise in pre-market trading Tuesday after the company said its new Xopenex inhaler for the treatment of asthma produced positive results in late-stage ...

Last warning: Asthma inhalers go "green" on Dec. 31, forcing patients still using the old-fashioned kind to make a pricey and even confusing switch. The medicine inside these rescue inhalers — the ...

Co confirms that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sepracor Inc. in connection with its Xopenex 0.31mg/3mL, 0.63mg/3mL and 1.25mg/3mL. On July ...